देश: कनाडा
भाषा: अंग्रेज़ी
स्रोत: Health Canada
AMOXICILLIN (AMOXICILLIN TRIHYDRATE); CLAVULANIC ACID (CLAVULANATE POTASSIUM)
APOTEX INC
J01CR02
AMOXICILLIN AND BETA-LACTAMASE INHIBITOR
500MG; 125MG
TABLET
AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 500MG; CLAVULANIC ACID (CLAVULANATE POTASSIUM) 125MG
ORAL
100
Prescription
AMINOPENICILLINS
Active ingredient group (AIG) number: 0234720009; AHFS:
APPROVED
2021-05-04
Page 1 of 35 PRODUCT MONOGRAPH, INCLUDING PATIENT MEDICATION INFORMATION PR APO-AMOXICILLIN-CLAVULANATE AMOXICILLIN AND CLAVULANATE POTASSIUM TABLETS USP 250 MG AMOXICILLIN AND 125 MG CLAVULANIC ACID / TABLET 500 MG AMOXICILLIN AND 125 MG CLAVULANIC ACID / TABLET 875 MG AMOXICILLIN AND 125 MG CLAVULANIC ACID / TABLET (AS AMOXICILLIN TRIHYDRATE AND CLAVULANATE POTASSIUM) COMBINATIONS OF PENICILLINS, INCLUDING BETA-LACTAMASE INHIBITORS APOTEX INC. DATE OF REVISION: 150 SIGNET DRIVE APRIL 30, 2021 TORONTO, ONTARIO M9L 1T9 CONTROL NO: 247608 Page 2 of 35 PRODUCT MONOGRAPH PR APO-AMOXICILLIN-CLAVULANATE Amoxicillin and Clavulanate Potassium Tablets USP 250 mg Amoxicillin and 125 mg Clavulanic Acid / Tablet 500 mg Amoxicillin and 125 mg Clavulanic Acid / Tablet 875 mg Amoxicillin and 125 mg Clavulanic Acid / Tablet (as Amoxicillin Trihydrate and Clavulanate Potassium) ANTIBIOTIC AND Β -LACTAMASE INHIBITOR ACTION Amoxicillin exerts a bactericidal action against sensitive organisms during the stage of active multiplication through the inhibition of the biosynthesis of bacterial cell wall mucopeptides. Clavulanic acid inhibits specific β -lactamases of some microorganisms and allows amoxicillin to inhibit amoxicillin (ampicillin) resistant organisms which produce clavulanic acid sensitive β - lactamases. INDICATIONS AND CLINICAL USE APO-AMOXICILLIN-CLAVULANATE (amoxicillin and clavulanate potassium) is indicated for the treatment of the following infections when caused by APO-AMOXICILLIN- CLAVULANATE -susceptible strains of the designated bacteria: Sinusitis when caused by β -lactamase producing strains of _H. influenzae_ or _Moraxella _ _(Branhamella) catarrhalis_. Otitis Media when caused by β -lactamase producing strains of _H. influenzae_ or _Moraxella (Branhamella) catarrhalis_. Lower Respiratory Tract Infections when caused by β -lactamase producing strains of _H. _ _influenzae, K. pneumoniae, S. aureus_ or _Moraxella (Branhamella) catarrhalis_. Skin and Soft Tissue Infections when caused by β -lactamase prod पूरा दस्तावेज़ पढ़ें